MedPath

A clinical trial to evaluate effects of Misoprostol by sublingual route after delivery of neonate in preventing postpatum bleeding in comparison to intramuscular injection of oxytocin.

Not Applicable
Completed
Conditions
Health Condition 1: null- Healthy women in labor without known risk factors for Postpartum hemorrhage were studied.
Registration Number
CTRI/2009/091/000672
Lead Sponsor
Chittaranjan Sevasadan HospitalSPMukherjee RoadKolkata
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
600
Inclusion Criteria

Women with live ,singleton ,term pregnancy in third stage of labor.

Exclusion Criteria

Multiple pregnancy,macrosomia,polyhydramnios,antepartum hemorrhage, hemoglobin below 8gm/dl,prolonged or obstructed labor,instrumental delivery,severe preeclampsia,cardiovascular,renal,hepatic or hematological disorder,known hypersensitivity to prostaglandins.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of PPH.Timepoint: 1 hour after delivery
Secondary Outcome Measures
NameTimeMethod
Amount of bleeding, Drop in Hb% ,Additional oxytocic requirement,duration of third stage of labor,need for manual removal of placenta,side effects and comlications.Timepoint: upto 24 hours postpartum.;Cost of oxytocic .Timepoint: after 1 hour.
© Copyright 2025. All Rights Reserved by MedPath